abstract gray background

Using Patient Experience Data to Demonstrate the Value of CAR-T Cell Therapies in Clinical Trials of Hematological Cancers

This paper examines the importance of: 

  • Patient input and experience data (PED) in understanding the impact of CAR-T cell therapy 
  • Opportunities and barriers in generating PED, emphasizing its importance in long-term follow-up 
  • Challenges in capturing patient perspectives for CAR-T treatments and potential solutions
Get the white paper
Patient-Experience-Data-in-CAR-T-thumbnail
Patient-Experience-Data-in-CAR-T_card

Using Patient Experience Data to Demonstrate the Value of CAR-T Cell Therapies in Clinical Trials of Hematological Cancers

Get the white paper